Avastin Drug Injury Prompts Recalls By The FDA
| March 26th, 2013
March 25, 2013 The U.S. Food and Drug Administration (FDA) announced the voluntary recall of all products made by two separate compounding companies due to contamination hazards. The agency issued a press release this past week indicating action was being taken in regards to Magnesium Sulfate injections made by Med Prep Consulting, Inc. The recall was initiated after several reports were received of particulate being discovered in bags of the intravenous solution. Further testing uncovered the particulate to be mold. The following day, it was announced all products manufactured by the company were being recalled because of contamination risks. On the same day as the initial recall for Med Prep products, the FDA also announced a similar recall on doses of the drug, Avastin®, packaged by the company, Clinical Specialties. Avastin® is used off-label as a treatment for macular degeneration. Officials say patients reportedly suffered an Avastin® Drug Injury, including internal eye infections, as a result of receiving an injection of the medication. Similar instances of infection that resulted in blindness have been documented in the past. The FDA says anyone in possession of either product have been instructed to halt its use immediately. The California Personal Injury Attorneys with Berg Injury Lawyers recognize the risks associated with the use of these products and are here to answer any questions you may have if you have been harmed by a medication prescribed to you by a doctor.
